Terminal › Stocks › GCTK

GlucoTrack, Inc. (GCTK) Stock

Healthcare · Medical - Instruments & Supplies · IL

$0.33 -18.22%

Last updated Jun 19, 2026 00:00 UTC

GCTK Key Statistics

Market Cap$186,097.20

P/E (TTM)-0.01

P/S (TTM)—

P/B (TTM)0.10

Revenue (TTM)$0.00

EPS (TTM)$-49.16

Dividend Yield—

ROE (TTM)-393.33%

Net Margin0.00%

Gross Margin0.00%

52W High$1.67

52W Low$0.33

Analyst View—

Price Target—

Employees11

Volume7,579,140

About GlucoTrack, Inc.

GlucoTrack, Inc., a medical device company, designs, develops, and commercializes non-invasive glucose monitoring devices for use by people suffering from diabetes and pre-diabetics in Israel and internationally. It develops GlucoTrack glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Or Yehuda, Israel.

CEO: Paul V. Goode. Company website

See GCTK live in QFI Terminal

Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.

Open GCTK in Terminal See plans

More Healthcare stocks

UNH UnitedHealth Group Incorporated CVS CVS Health Corporation MCK McKesson Corporation COR Cencora, Inc. NVO Novo Nordisk A/S CI Cigna Corporation CAH Cardinal Health, Inc. ELV Elevance Health Inc.